Translational Chemical Biology: Hunt for Next Generation Chemical Probes/Drug Candidates in the Cancer Cell Signaling Arena.

Similar documents
Recent years have witnessed an expansion in the disciplines encompassing drug

FRAUNHOFER IME SCREENINGPORT

Druggability & DruGUI. Ahmet Bakan Department of Computational and Systems Biology

EOS: a Focussed Oncology Company Overview Forum della Ricerca e dell Innovazione Padova, May 16, 2008

Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases

Introduction to Assay Development

Advancing Life Sciences

Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas

Design, docking study and ADME prediction of Chalcone derivatives as potent Tubulin inhibitors

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

The Integrated Biomedical Sciences Graduate Program

TARGET VALIDATION. Maaike Everts, PhD (with slides from Dr. Suto)

Case Studies ZoBio

University of Pennsylvania Perelman School of Medicine High Throughput Screening Core

Innovative Medicines Initiative

Recent Progress of Interprotein s Research Activities. Interprotein Corporation

Biomolecular Characterization for Rational Drug Design. Maria João Romão

Allosteric inhibitors of the NS3 protease from the hepatitis C virus with a new action mechanism

Centre for Drug Design and Discovery CD3. Centre for Drug Design and Discovery

Genomics Research Center: Current Status & Future Development

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW

Proteomics. Manickam Sugumaran. Department of Biology University of Massachusetts Boston, MA 02125

Docking Studies of the Binding Mode of Dictyostatin and Its Analogues to the Taxoid Binding Site on Tubulin

Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research

Fragment-based screening of enzyme drug targets: Microfluidic mobility shift assay improves confidence in candidate selection

DHODH: StructureGuided Design of a. New Class of Drugs. Defeating Malaria Together. Meg Phillips, Ph.D. UT Southwestern

KNIME as a Platform for Integrated Hit Finding at Novartis. Patrick S. Lee Ph.D. KNIME Fall Summit 2016 San Francisco 9/16/2016

Dr Amy Prosser Careers in Research: Industry

MANIFESTO OF STUDIES 2012

A Review on Microdosing: Reduction in Cost & Time

Program overview. SciLifeLab - a short introduction. Advanced Light Microscopy. Affinity Proteomics. Bioinformatics.

Pharmaceutical Informatics and the Pathway to Personalized Medicines

BIOL 461/ 661 Cell Biology 4 Credits Instructor: Dr. Kristin O Brien. T/TH 11:30-1:00, Irving I 208 Office hours: M 9-10, TH 3-4

The Major Function Of Rna Is To Carry Out The Genetic Instructions For Protein Synthesis

Hitting the target in phenotypic drug discovery: Advances in receptor deconvolution

Introduction to Drug Design and Discovery

Part I. Progress toward the Total Synthesis of Tubulysin Analogs

Computational methods in drug discovery

Current Research. Examples of current research projects:

Antibody Discovery at Evotec

Small-Molecule Drug Target Identification/Deconvolution Technologies

Drug Discovery and Development at NIH for Rare and Neglected Diseases September 29, 2009

How Targets Are Chosen. Chris Wayman 12 th April 2012

NANYANG TECHNOLOGICAL UNIVERSITY SEMESTER I EXAMINATION CBC922 Medicinal Chemistry. NOVEMBER TIME ALLOWED: 120 min

Marine Genetic Resources: Experiences in Commercialization. Background

Includes 'study abroad' Description This lecture module will introduce the following topics: Assessment Assessment Type Exam 1 (100%) Convenor

Discovery and Development of Highly Selective and Orally Bioavailable Macrocyclic IDO-1 Inhibitors

GE Healthcare Life Sciences. A year of interaction with Biacore X100

Potencial de los productos naturales marinos como agentes anticáncer: La situación de Panamá

Chemical Biology In-class discussion: Tethering

Pharmacophore modeling, virtual computational screening and biological evaluation studies

Compound Re-Profiling. Dr Robert Scoffin CEO, Cresset

6th Form Open Day 15th July 2015

Impact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation

Madagascar periwinkle (Catharanthus roseus) Salix - willow. Biodiversity: Use it or lose it. Biodiversity: Use it or lose it

Section 10. Junaid Malek, M.D.

Innovative Strategies to Accelerate Academic Drug Discovery. Vincent Groppi, Ph.D Director Center for the Discovery of New Medicines

Competing & Collaborating to Achieve Successful Drug Repositioning

CONTRACTING ORGANIZATION: Dana Farber Cancer Institute Boston, MA 02115

Tanja Krainz Current Literature July 9 th, 2016

Using Computational Chemistry to Identify New Uses for Old Medicines

Overview and Status Update

Generation of research tools to translate genomic discoveries into drug discovery projects. Nils Ostermann, Novartis

BIO8041 BIO3030. Antimicrobial Drug Discovery

OTC-BB STOCK SYMBOL: ENZB EXECUTIVE SUMMARY

North Carolina Research Campus Kannapolis, NC

20S Proteasome Assay Kit

Application of Deep Learning to Drug Discovery

COURSES IN BIOLOGICAL SCIENCE. Undergraduate Courses Postgraduate Courses

Marineinspired Oncology

MANIFESTO OF STUDIES 2013

= -1-EUROPEAN CD3. "Stimulating innovation in drug discovery" 21 May 2010 Innovation in Healthcare. Centre for Drug Design and Discovery

Polypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab

Concept of Integrated Research Platforms

Medicinal Chemistry of Modern Antibiotics

Medicinal Chemistry of Modern Antibiotics

DNA REPLICATION & BIOTECHNOLOGY Biology Study Review

Advanced Therapeutic Antibody Discovery with Multiplexed Screening

Chemical Peptide Synthesis in the Development of Protein Therapeutics

Application of Deep Learning to Drug Discovery

Targeting the Functional Activity of PrP C as a Novel Strategy for Drug Discovery in Prion Diseases

March 8 [FRI], :00-17:00. - Program -

Targeted Protein Degradation Therapeutics

The main goal of the strategic partnership is the development of innovative, all-natural cosmetic active ingredients and aroma molecules.

Time allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question in Section B and ONE question from Section C.

SUPPLEMENTARY INFORMATION Figures. Supplementary Figure 1 a. Page 1 of 30. Nature Chemical Biology: doi: /nchembio.2528

leading the way in research & development

Time-resolved interaction analysis on living cells: Comprehensive data generates new knowledge and better decisions

The ChEMBL Database. ICIC 2012 Berlin, Germany October John P. Overington EMBL- EBI.

Dennis Wright, Ph.D. Professor of Medicinal Chemistry NPDD Initiative UCONN School of Pharmacy University of Connecticut

Development and Utilization of Bromodomain and Extra Terminal Domain (BET) Assays Using AlphaLISA Technology

Introducing the Department of Life Sciences

The Kinase Knowledgebase

Fig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.

Centre for Synthetic Biology

Products & Services. Customers. Example Customers & Collaborators

TITLE: Prostate Specific Antigen-Triggered Prodrug of S-Trityl-L-Cysteine, an Eg5 Kinesin Inhibitor and Antimitosis Agent with Low Neurotoxicity

Course Handbook MSc in Bioengineering Tissue Engineering Specialisation

Practical Workshop: Chemical Biology, Drug Discovery and Screening

Sabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials

Transcription:

Translational Chemical Biology: unt for Next Generation Chemical Probes/Drug Candidates in the Cancer Cell Signaling Arena Prabhat Arya 1

small molecule binder From enzymes /isolated protein targets Rethinking Drug Discovery Pharma Focus Asia, Nov 2014 Well defined Compact Deep pocket Protein complexes/ signaling pathways 2

Map large surface area Shallow surface Combination of several weak interactions Extended hydrophobic interactions Possible hot spots May 14, 2014 Issue Theme: Chemical Biology of Protein-Protein Interactions 3

Natural Products as Modulators of PPIs Me Me Me Me N Me FK506 Me Me Me 2 N Eribulin Complex 3D architectures! Dense display of stereo-defined groups 4

Growing Faith in the Emerging Chemical Biology Model Modern rganic Synthesis Novel Chemical Toolbox Biologically Relevant Chemical Space Natural Product-like Natural Product-inspired ybrid Natural Products Cell Signaling Biology (Biological Questions/ Novel Assays) Cellular Assays Zebrafish Assays ther rganisms Biophysics and Structural Biology SPR Protein NMR Computational Tools 5

Exploring Biologically Relevant Chemical Space Bioactive Natural Products Building Macrocyclic Diversity-based Chemical Toolbox Natural Product- Inspired Substructures Natural product-like 3D architectures Sufficient complexity with a few chiral functional groups Incorporation of stereochemical and skeletal diversity Synthesis in a reasonable time-scale Easy to carry-out follow-up medicinal chemistry studies From Arya Research Team: Chem. & Biol. 145 (2002) and 163 (2005) Curr. pin. Chem. Biol. 247 (2005) Chem. Rev. 1999 (2009)

Large 3D surface area Numerous binding interactions Excellent track record in finding bioactives Functionalized pre-organized dynamic Shapes Rich in chiral display of functional groups Nat. Rev. Drug Disc. 2008, 7, 608-624 7

Building A Chemical Toolbox Me Rapamycin N S Latrunculol A N Me Me 2 N Eribulin Epothilone/Ixabepilone 8

Latrunculins as Actin Modulators Isolated from Red Sea sponge Negombata magnifica Potent G-actin Inhibitors Latrunculol A is more potent compared to other family members J. Med. Chem. 2008, 51, 7234 7242 9

Latrunculin-derived ybrid Macrocycles Diversity site R 1 N R1 N 13 15 13 15 17 17 Me Me PMBN PMBN Madhu Aeluri S S 10

Synthesis of ybrid Macrocycles TBDPS Me PMBN S i. Na, allyl bromide DMF,RT,5h 13 15 13 15 ii.tbaf,tf,rt,1h 70%for2steps ~10.0 gms scale Me PMBN S R N EDCI, DMAP, DCM RT,4h,85-90% R N R N Me PMBN S i.g-ii(10mol%) DCM,reflux,3h 13 15 13 15 ii. 2,10%Pd/C Et,RT,12h 60%for2steps Me PMBN S R=i-Pr R=Bn R=i-Bu R=s-Bu R=Me Aeluri, Dasari, Arya, rg. Lett. 2015 ASAP 11

Eribulin as A Tubulin Binder FDA approved anticancer drug (Nov, 2010) marketed by Esai Synthetic analog of a marine sponge natural product, alichondrin B Mechanistically, a unique inhibitor of microtubule dynamics 12

ur 1 st Generation ybrid Macrocycles Eribulin 32 30 Macrocycle-12 29 N R Jimmidi, Krishna Reddy, Arya rg. Lett. 2015 ASAP Ravi Kumar Jimmidi 13

ybrid Rapamycins Nat Rev Cancer 2006 Me N Me Me Nat Rev Neuroscience 2011 14

ur 1 st Generation Plan Shiva Krishna Reddy Guduru Me 34 32 7 N 1 11 10 8 9 14 Me 16 Me 18 22 26 Practical and scalable synthesis 22-membered macrocyclic ring Imbedded Amino alcohol moiety as the diversity site 11 9 10 14 8 7 N 1 R 2 16 N 18 R 1 Krishna Reddy Guduru, Jimmidi, Deora, Arya rg. Lett. 2015 ASAP 15

Collaborative Study: Probing Cancer Stem Cells by Small Molecules Dr. Satish Kitambi Dept of Medical Biochem and Biophysics, Karolinska Institutet Dr. Subhadra Dravida Tran-Scell Biologics yderabad www.tran-scell.com Dr. Kiranam Chatti DRILS yderabad (Zebrafish / Cytoskeleton Signaling) Dr. Prasenjit Mitra DRILS yderabad (Mitochondria Signaling) 16

Nat. Rev. Drug Discovery July 2014 17

Nat. Rev. Drug Discovery July 2014 18

ur Collaborative Roadmap Isolation of Cancer Stem Cells (CSCs) from human brain tumor. Validation of Cancer Stem Cells. Identification of small molecules as highly selective killers of CSCs. Understanding of specific pathways affected by small molecule hits! Cell survival assays using CSCs vs cancer cells. Cell survival, proliferation and migration assays with CSCs in zebrafish. 19

Cell 2009 Salinomycin C 20

Cell 2014 Kitambi Lab @ Karolinska 21

Cell Viability Assay (Cancer Stem Cells Derived from uman Brain Tumor Cells) Inte ensity (a. u) ATP measurement! Me Me N N N NMe from our toolbox Apoptosis inducer (by Caspase 3 activation) Compounds Kitambi Lab @ Karolinska 22

Cancer Stem Cells: Proliferation and Cell Migration in Zebrafish Model! Lateral view of 2 days old zebrafish larvae with DAPI (stains all the nucleus as blue) and the newly transplanted CSC in red Dorsal view of approximately 1 month old zebrafish transplanted with CSCs labelled red brain brain eye Cancer Stem Cells Kitambi Lab @ Karolinska 23

Sincere Thanks to Arya Academic Research Team in Canada (past) and India (2009- present) NRC Canada Genomics and ealth Initiative Science and Technology Park University of Pune Chemical Biology McGill University Chemical Biology Program Broad Institute of arvard and MIT